Leonardo Caló

Corporate Officer/Principal at OMEICOS Therapeutics GmbH

Health Technology

Leonardo Caló active positions

Companies	Position	Start
OMEICOS Therapeutics GmbH OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany.	Corporate Officer/Principal	-

All active positions of Leonardo Caló

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Leonardo Caló's experience

Connections

11

1st degree connections

1

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies

1

Health Technology

See company connections

Stock Market
Insiders
Leonardo Caló

Protect and grow your investments with the help of our experts

Securing my Investments

fermer